{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T15:41:34Z","timestamp":1774021294078,"version":"3.50.1"},"reference-count":103,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2016,11,4]],"date-time":"2016-11-04T00:00:00Z","timestamp":1478217600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Spanish Government and EU funds","award":["FIS PI13\/00089"],"award-info":[{"award-number":["FIS PI13\/00089"]}]},{"name":"La Marat\u00f3 de TV3 Foundation","award":["20132730"],"award-info":[{"award-number":["20132730"]}]},{"name":"FCT (Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia)","award":["UID\/BIM\/04501\/2013"],"award-info":[{"award-number":["UID\/BIM\/04501\/2013"]}]},{"name":"FCT (Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia)","award":["SFRH\/BPD\/91766\/2012"],"award-info":[{"award-number":["SFRH\/BPD\/91766\/2012"]}]},{"name":"Proteostasis COST Action","award":["BM1307"],"award-info":[{"award-number":["BM1307"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0165973","type":"journal-article","created":{"date-parts":[[2016,11,4]],"date-time":"2016-11-04T17:29:12Z","timestamp":1478280552000},"page":"e0165973","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":53,"title":["From Proteomic Analysis to Potential Therapeutic Targets: Functional Profile of Two Lung Cancer Cell Lines, A549 and SW900, Widely Studied in Pre-Clinical Research"],"prefix":"10.1371","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2811-8081","authenticated-orcid":true,"given":"Lu\u00eds","family":"Korrodi-Greg\u00f3rio","sequence":"first","affiliation":[]},{"given":"Vanessa","family":"Soto-Cerrato","sequence":"additional","affiliation":[]},{"given":"Rui","family":"Vitorino","sequence":"additional","affiliation":[]},{"given":"Margarida","family":"Fardilha","sequence":"additional","affiliation":[]},{"given":"Ricardo","family":"P\u00e9rez-Tom\u00e1s","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2016,11,4]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"D Hanahan","year":"2000","journal-title":"Cell"},{"issue":"5","key":"ref2","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"D Hanahan","year":"2011","journal-title":"Cell"},{"issue":"9","key":"ref3","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1200\/JCO.2005.02.047","article-title":"Role of transforming growth factor Beta in human cancer","volume":"23","author":"RL Elliott","year":"2005","journal-title":"J Clin Oncol"},{"issue":"6","key":"ref4","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","article-title":"Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012","volume":"49","author":"J Ferlay","year":"2013","journal-title":"Eur J Cancer"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.trsl.2014.03.001","article-title":"Epigenetics of lung cancer","volume":"165","author":"SM Langevin","year":"2015","journal-title":"Transl Res"},{"issue":"Suppl 1","key":"ref6","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1038\/modpathol.2011.150","article-title":"Update on small cell carcinoma and its differentiation from squamous cell carcinoma and other non-small cell carcinomas","volume":"25","author":"WD Travis","year":"2012","journal-title":"Mod Pathol"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/jnci\/51.5.1417","article-title":"In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors","volume":"51","author":"DJ Giard","year":"1973","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/ijc.2910170110","article-title":"A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells","volume":"17","author":"M Lieber","year":"1976","journal-title":"Int J Cancer"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/jnci\/59.1.221","article-title":"One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice","volume":"59","author":"J Fogh","year":"1977","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ccr.2013.03.009","article-title":"The pivotal role of IKKalpha in the development of spontaneous lung squamous cell carcinomas","volume":"23","author":"Z Xiao","year":"2013","journal-title":"Cancer Cell"},{"issue":"42","key":"ref11","doi-asserted-by":"crossref","first-page":"16868","DOI":"10.1073\/pnas.1306358110","article-title":"CRL4A-FBXW5-mediated degradation of DLC1 Rho GTPase-activating protein tumor suppressor promotes non-small cell lung cancer cell growth","volume":"110","author":"TY Kim","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1756-9966-29-74","article-title":"Comparison of the inhibitory effects of three transcriptional variants of CDKN2A in human lung cancer cell line A549","volume":"29","author":"W Zhang","year":"2010","journal-title":"J Exp Clin Cancer Res"},{"issue":"24","key":"ref13","first-page":"6200","article-title":"Multiple mechanisms of p16INK4A inactivation in non-small cell lung cancer cell lines","volume":"55","author":"GI Shapiro","year":"1995","journal-title":"Cancer Res"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/mc.20607","article-title":"KRAS mutant lung cancer cells are differentially responsive to MEK inhibitor due to AKT or STAT3 activation: implication for combinatorial approach","volume":"49","author":"YK Yoon","year":"2010","journal-title":"Mol Carcinog"},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1177\/1947601911411084","article-title":"Ras in cancer and developmental diseases","volume":"2","author":"A Fernandez-Medarde","year":"2011","journal-title":"Genes Cancer"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/sj.bjc.6604886","article-title":"LKB1\/KRAS mutant lung cancers constitute a genetic subset of NSCLC with increased sensitivity to MAPK and mTOR signalling inhibition","volume":"100","author":"CL Mahoney","year":"2009","journal-title":"Br J Cancer"},{"issue":"14","key":"ref17","doi-asserted-by":"crossref","first-page":"5923","DOI":"10.1158\/0008-5472.CAN-10-0655","article-title":"Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34","volume":"70","author":"JF Wiggins","year":"2010","journal-title":"Cancer Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1477-5956-8-9","article-title":"A novel method for sample preparation of fresh lung cancer tissue for proteomics analysis by tumor cell enrichment and removal of blood contaminants","volume":"8","author":"L De Petris","year":"2010","journal-title":"Proteome Sci"},{"issue":"13","key":"ref19","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1002\/pmic.200500883","article-title":"Plasma proteomics of lung cancer by a linkage of multi-dimensional liquid chromatography and two-dimensional difference gel electrophoresis","volume":"6","author":"T Okano","year":"2006","journal-title":"Proteomics"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1471-2407-5-83","article-title":"Application of serum SELDI proteomic patterns in diagnosis of lung cancer","volume":"5","author":"SY Yang","year":"2005","journal-title":"BMC Cancer"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s00216-012-6203-4","article-title":"Quantitative mass spectrometry in proteomics: critical review update from 2007 to the present","volume":"404","author":"M Bantscheff","year":"2012","journal-title":"Anal Bioanal Chem"},{"issue":"7","key":"ref22","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1021\/pr900080y","article-title":"A comparison of labeling and label-free mass spectrometry-based proteomics approaches","volume":"8","author":"VJ Patel","year":"2009","journal-title":"J Proteome Res"},{"issue":"9","key":"ref23","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1074\/mcp.M500061-MCP200","article-title":"Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein","volume":"4","author":"Y Ishihama","year":"2005","journal-title":"Mol Cell Proteomics"},{"key":"ref24","unstructured":"Oliveros JC. VENNY. An interactive tool for comparing lists with Venn Diagrams2007."},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1038\/ncomms3617","article-title":"Reconstructing targetable pathways in lung cancer by integrating diverse omics data","volume":"4","author":"OA Balbin","year":"2013","journal-title":"Nat Commun"},{"issue":"9","key":"ref26","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1002\/pmic.200500652","article-title":"Functional analysis of the nuclear proteome of human A549 alveolar epithelial cells by HPLC-high resolution 2-D gel electrophoresis","volume":"6","author":"J Forbus","year":"2006","journal-title":"Proteomics"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00432-010-0913-9","article-title":"Comparative proteomic analysis of paclitaxel sensitive A549 lung adenocarcinoma cell line and its resistant counterpart A549-Taxol","volume":"137","author":"QL Sun","year":"2011","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"ref28","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1039\/C0MB00055H","article-title":"Phosphoproteome profile of human lung cancer cell line A549","volume":"7","author":"G Yu","year":"2011","journal-title":"Mol Biosyst"},{"issue":"4","key":"ref29","first-page":"229","article-title":"Comparative proteomic analysis of lung cancer cell line and lung fibroblast cell line","volume":"6","author":"A Rubporn","year":"2009","journal-title":"Cancer Genomics Proteomics"},{"issue":"6220","key":"ref30","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"M Uhlen","year":"2015","journal-title":"Science"},{"issue":"8","key":"ref31","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1152\/physiolgenomics.00178.2010","article-title":"VeryGene: linking tissue-specific genes to diseases, drugs, and beyond for knowledge discovery","volume":"43","author":"X Yang","year":"2011","journal-title":"Physiol Genomics"},{"issue":"18","key":"ref32","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1093\/bioinformatics\/btq417","article-title":"C-It: a knowledge database for tissue-enriched genes","volume":"26","author":"P Gellert","year":"2010","journal-title":"Bioinformatics"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/1471-2105-9-271","article-title":"TiGER: a database for tissue-specific gene expression and regulation","volume":"9","author":"X Liu","year":"2008","journal-title":"BMC Bioinformatics"},{"issue":"11","key":"ref34","doi-asserted-by":"crossref","first-page":"R130","DOI":"10.1186\/gb-2009-10-11-r130","article-title":"BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources","volume":"10","author":"C Wu","year":"2009","journal-title":"Genome Biol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"W505","DOI":"10.1093\/nar\/gks445","article-title":"SteinerNet: a web server for integrating 'omic' data to discover hidden components of response pathways","volume":"40","author":"N Tuncbag","year":"2012","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"ref36","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"P Shannon","year":"2003","journal-title":"Genome Res"},{"issue":"2","key":"ref37","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/bioinformatics\/btm554","article-title":"Computing topological parameters of biological networks","volume":"24","author":"Y Assenov","year":"2008","journal-title":"Bioinformatics"},{"issue":"8","key":"ref38","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/bioinformatics\/btp101","article-title":"ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks","volume":"25","author":"G Bindea","year":"2009","journal-title":"Bioinformatics"},{"issue":"1","key":"ref39","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1021\/pr100491e","article-title":"Primary tumor xenografts of human lung adeno and squamous cell carcinoma express distinct proteomic signatures","volume":"10","author":"Y Wei","year":"2011","journal-title":"J Proteome Res"},{"issue":"6","key":"ref40","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/pmic.201300382","article-title":"Proteomic profiles of human lung adeno and squamous cell carcinoma using super-SILAC and label-free quantification approaches","volume":"14","author":"W Zhang","year":"2014","journal-title":"Proteomics"},{"issue":"3","key":"ref41","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1083\/jcb.200103078","article-title":"Keratin attenuates tumor necrosis factor-induced cytotoxicity through association with TRADD","volume":"155","author":"H Inada","year":"2001","journal-title":"J Cell Biol"},{"issue":"1","key":"ref42","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3892\/ol.2012.959","article-title":"Annexin A1, A2, A4 and A5 play important roles in breast cancer, pancreatic cancer and laryngeal carcinoma, alone and\/or synergistically","volume":"5","author":"S Deng","year":"2013","journal-title":"Oncol Lett"},{"issue":"4","key":"ref43","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1517\/14728222.2014.882323","article-title":"Annexin A4 is a promising therapeutic target for the treatment of platinum-resistant cancers","volume":"18","author":"S Matsuzaki","year":"2014","journal-title":"Expert Opin Ther Targets"},{"issue":"11","key":"ref44","doi-asserted-by":"crossref","first-page":"e78610","DOI":"10.1371\/journal.pone.0078610","article-title":"Fhit delocalizes annexin a4 from plasma membrane to cytosol and sensitizes lung cancer cells to paclitaxel","volume":"8","author":"E Gaudio","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"ref45","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.3390\/ijms14022652","article-title":"Annexin-phospholipid interactions. Functional implications","volume":"14","author":"MA Lizarbe","year":"2013","journal-title":"Int J Mol Sci"},{"issue":"6","key":"ref46","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1042\/BST20120199","article-title":"Novel functions for Rab GTPases in multiple aspects of tumour progression","volume":"40","author":"C Recchi","year":"2012","journal-title":"Biochem Soc Trans"},{"issue":"Pt 6","key":"ref47","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1242\/jcs.096040","article-title":"CD98 at the crossroads of adaptive immunity and cancer","volume":"125","author":"JM Cantor","year":"2012","journal-title":"J Cell Sci"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1741-7015-9-28","article-title":"Nuclear envelope structural defects cause chromosomal numerical instability and aneuploidy in ovarian cancer","volume":"9","author":"CD Capo-chichi","year":"2011","journal-title":"BMC Med"},{"issue":"8","key":"ref49","doi-asserted-by":"crossref","first-page":"e23882","DOI":"10.1371\/journal.pone.0023882","article-title":"Matrin 3 binds and stabilizes mRNA","volume":"6","author":"M Salton","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"ref50","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/labinvest.2014.124","article-title":"Overexpression of stathmin 1 is a poor prognostic biomarker in non-small cell lung cancer","volume":"95","author":"W Nie","year":"2015","journal-title":"Lab Invest"},{"key":"ref51","article-title":"Overexpression of stathmin is resistant to paclitaxel treatment in patients with non-small cell lung cancer","author":"R Sun","year":"2015","journal-title":"Tumour Biol"},{"issue":"1","key":"ref52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1165\/rcmb.2013-0314TR","article-title":"The role of vimentin intermediate filaments in the progression of lung cancer","volume":"50","author":"ME Kidd","year":"2014","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"2","key":"ref53","doi-asserted-by":"crossref","first-page":"586","DOI":"10.2353\/ajpath.2010.091217","article-title":"S100A6 overexpression is associated with poor prognosis and is epigenetically up-regulated in gastric cancer","volume":"177","author":"XH Wang","year":"2010","journal-title":"Am J Pathol"},{"issue":"6","key":"ref54","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1093\/carcin\/bgt040","article-title":"Galectin-1 promotes lung cancer tumor metastasis by potentiating integrin alpha6beta4 and Notch1\/Jagged2 signaling pathway","volume":"34","author":"YL Hsu","year":"2013","journal-title":"Carcinogenesis"},{"issue":"15","key":"ref55","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1158\/1078-0432.CCR-11-3348","article-title":"Galectin-1 promotes lung cancer progression and chemoresistance by upregulating p38 MAPK, ERK, and cyclooxygenase-2","volume":"18","author":"LY Chung","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"22","key":"ref56","doi-asserted-by":"crossref","first-page":"6486","DOI":"10.1158\/0008-5472.CAN-14-0061","article-title":"BRG1\/SMARCA4 inactivation promotes non-small cell lung cancer aggressiveness by altering chromatin organization","volume":"74","author":"T Orvis","year":"2014","journal-title":"Cancer Res"},{"issue":"5","key":"ref57","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/humu.20730","article-title":"Frequent BRG1\/SMARCA4-inactivating mutations in human lung cancer cell lines","volume":"29","author":"PP Medina","year":"2008","journal-title":"Hum Mutat"},{"issue":"2","key":"ref58","doi-asserted-by":"crossref","first-page":"e31826","DOI":"10.1371\/journal.pone.0031826","article-title":"HIPPIE: Integrating protein interaction networks with experiment based quality scores","volume":"7","author":"MH Schaefer","year":"2012","journal-title":"PLoS One"},{"issue":"9","key":"ref59","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1101\/gad.1528707","article-title":"Getting connected: analysis and principles of biological networks","volume":"21","author":"X Zhu","year":"2007","journal-title":"Genes Dev"},{"issue":"Pt 21","key":"ref60","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1242\/jcs.02714","article-title":"Scale-free networks in cell biology","volume":"118","author":"R Albert","year":"2005","journal-title":"J Cell Sci"},{"issue":"4","key":"ref61","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/nprot.2012.004","article-title":"Topological analysis and interactive visualization of biological networks and protein structures","volume":"7","author":"NT Doncheva","year":"2012","journal-title":"Nat Protoc"},{"issue":"4","key":"ref62","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1371\/journal.pcbi.0030059","article-title":"The importance of bottlenecks in protein networks: correlation with gene essentiality and expression dynamics","volume":"3","author":"H Yu","year":"2007","journal-title":"PLoS Comput Biol"},{"issue":"6995","key":"ref63","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nature02555","article-title":"Evidence for dynamically organized modularity in the yeast protein-protein interaction network","volume":"430","author":"JD Han","year":"2004","journal-title":"Nature"},{"issue":"1","key":"ref64","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1158\/0008-5472.CAN-05-2367","article-title":"Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt\/mammalian target of rapamycin\/S6 kinase and inactivation of LKB1\/AMP-activated protein kinase signal pathways","volume":"66","author":"S Han","year":"2006","journal-title":"Cancer Res"},{"issue":"2","key":"ref65","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3727\/096504013X13747716581417","article-title":"Ran GTPase induces EMT and enhances invasion in non-small cell lung cancer cells through activation of PI3K-AKT pathway","volume":"21","author":"J Ning","year":"2013","journal-title":"Oncol Res"},{"issue":"2","key":"ref66","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/jnci\/84.2.113","article-title":"Determinants of response to the DNA topoisomerase II inhibitors doxorubicin and etoposide in human lung cancer cell lines","volume":"84","author":"K Kasahara","year":"1992","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"ref67","first-page":"3809","article-title":"DNA breakage in human lung carcinoma cells and nuclei that are naturally sensitive or resistant to etoposide and teniposide","volume":"46","author":"BH Long","year":"1986","journal-title":"Cancer Res"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.mam.2015.06.009","article-title":"Biomarkers and targeted systemic therapies in advanced non-small cell lung cancer","volume":"45","author":"M Kumar","year":"2015","journal-title":"Mol Aspects Med"},{"issue":"6","key":"ref69","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1139\/o04-116","article-title":"Order or chaos? An evaluation of the regulation of protein kinase CK2","volume":"82","author":"ME Olsten","year":"2004","journal-title":"Biochem Cell Biol"},{"issue":"8","key":"ref70","first-page":"2262","article-title":"Activation of a tumor-associated protein kinase (p40TAK) and casein kinase 2 in human squamous cell carcinomas and adenocarcinomas of the lung","volume":"54","author":"M Daya-Makin","year":"1994","journal-title":"Cancer Res"},{"issue":"14","key":"ref71","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.1128\/MCB.00120-08","article-title":"Nuclear factor 45 (NF45) is a regulatory subunit of complexes with NF90\/110 involved in mitotic control","volume":"28","author":"D Guan","year":"2008","journal-title":"Mol Cell Biol"},{"issue":"3","key":"ref72","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10549-005-9009-7","article-title":"Gene expression patterns for doxorubicin (Adriamycin) and cyclophosphamide (cytoxan) (AC) response and resistance","volume":"95","author":"S Cleator","year":"2006","journal-title":"Breast Cancer Res Treat"},{"issue":"24","key":"ref73","doi-asserted-by":"crossref","first-page":"8213","DOI":"10.1158\/1078-0432.CCR-08-0095","article-title":"Confirmation of gene expression-based prediction of survival in non-small cell lung cancer","volume":"14","author":"NL Guo","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"7","key":"ref74","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M111.013243","article-title":"Interleukin enhancer-binding factor 3\/NF110 is a target of YM155, a suppressant of survivin","volume":"11","author":"N Nakamura","year":"2012","journal-title":"Mol Cell Proteomics"},{"issue":"6","key":"ref75","first-page":"331","article-title":"Apoptotic regulators: P53 and survivin expression in non-small cell lung cancer","volume":"7","author":"I Porebska","year":"2010","journal-title":"Cancer Genomics Proteomics"},{"issue":"3","key":"ref76","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00428-013-1462-9","article-title":"Survivin expression is an independent poor prognostic marker in lung adenocarcinoma but not in squamous cell carcinoma","volume":"463","author":"PL Sun","year":"2013","journal-title":"Virchows Arch"},{"issue":"Pt 15","key":"ref77","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1242\/jcs.00653","article-title":"Proliferating cell nuclear antigen (PCNA): a dancer with many partners","volume":"116","author":"G Maga","year":"2003","journal-title":"J Cell Sci"},{"issue":"Pt 3","key":"ref78","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1042\/BST0370605","article-title":"PCNA on the crossroad of cancer","volume":"37","author":"I Stoimenov","year":"2009","journal-title":"Biochem Soc Trans"},{"issue":"1","key":"ref79","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1158\/1535-7163.MCT-10-0778","article-title":"Targeting tyrosine phosphorylation of PCNA inhibits prostate cancer growth","volume":"10","author":"H Zhao","year":"2011","journal-title":"Mol Cancer Ther"},{"issue":"9","key":"ref80","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/S0959-8049(03)00232-6","article-title":"Prognostic significance of K-ras, p53, bcl-2, PCNA, CD34 in radically resected non-small cell lung cancers","volume":"39","author":"F Grossi","year":"2003","journal-title":"Eur J Cancer"},{"issue":"9","key":"ref81","first-page":"2496","article-title":"Relationship of p53 overexpression and up-regulation of proliferating cell nuclear antigen with the clinical course of non-small cell lung cancer","volume":"54","author":"M Ebina","year":"1994","journal-title":"Cancer Res"},{"issue":"6","key":"ref82","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/BF01225691","article-title":"P53 accumulation and proliferating-cell nuclear antigen expression in human lung cancer","volume":"121","author":"T Wiethege","year":"1995","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"ref83","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1078\/S0065-1281(04)70039-2","article-title":"Expression of cyclin D1, Ki-67 and PCNA in non-small cell lung cancer: prognostic significance and comparison with p53 and bcl-2","volume":"102","author":"VN Nguyen","year":"2000","journal-title":"Acta Histochem"},{"issue":"10","key":"ref84","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1074\/mcp.M111.015370","article-title":"In-depth proteomic analysis of nonsmall cell lung cancer to discover molecular targets and candidate biomarkers","volume":"11","author":"T Kikuchi","year":"2012","journal-title":"Mol Cell Proteomics"},{"issue":"5","key":"ref85","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.3892\/ijo.2014.2318","article-title":"The translation elongation factor eEF2 is a novel tumorassociated antigen overexpressed in various types of cancers","volume":"44","author":"Y Oji","year":"2014","journal-title":"Int J Oncol"},{"issue":"2","key":"ref86","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ccr.2011.01.002","article-title":"NEDD8 pathways in cancer, Sine Quibus Non","volume":"19","author":"IR Watson","year":"2011","journal-title":"Cancer Cell"},{"issue":"7","key":"ref87","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1177\/1947601910382898","article-title":"The NEDD8 Conjugation Pathway and Its Relevance in Cancer Biology and Therapy","volume":"1","author":"TA Soucy","year":"2010","journal-title":"Genes Cancer"},{"issue":"7239","key":"ref88","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/nature07884","article-title":"An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer","volume":"458","author":"TA Soucy","year":"2009","journal-title":"Nature"},{"issue":"1","key":"ref89","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1476-4598-5-55","article-title":"Pathway-specific differences between tumor cell lines and normal and tumor tissue cells","volume":"5","author":"A Ertel","year":"2006","journal-title":"Mol Cancer"},{"issue":"8","key":"ref90","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1186\/gb-2005-6-8-r65","article-title":"The molecular portrait of in vitro growth by meta-analysis of gene-expression profiles","volume":"6","author":"R Sandberg","year":"2005","journal-title":"Genome Biol"},{"issue":"1","key":"ref91","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.intimp.2015.05.033","article-title":"Mechanisms of growth-promoting and tumor-protecting effects of epithelial nicotinic acetylcholine receptors","volume":"29","author":"AI Chernyavsky","year":"2015","journal-title":"Int Immunopharmacol"},{"key":"ref92","article-title":"Inhibition of microRNA-196a might reverse cisplatin resistance of A549\/DDP non-small-cell lung cancer cell line","author":"JH Li","year":"2015","journal-title":"Tumour Biol"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.biomaterials.2014.11.029","article-title":"Synergism through combination of chemotherapy and oxidative stress-induced autophagy in A549 lung cancer cells using redox-responsive nanohybrids: a new strategy for cancer therapy","volume":"42","author":"HY Lu","year":"2015","journal-title":"Biomaterials"},{"key":"ref94","article-title":"Anti-HER3 monoclonal antibody patritumab sensitizes refractory non-small cell lung cancer to the epidermal growth factor receptor inhibitor erlotinib","author":"K Yonesaka","year":"2015","journal-title":"Oncogene"},{"issue":"5","key":"ref95","first-page":"991","article-title":"Comparison of features of human lung cancer cell lines and their corresponding tumors","volume":"5","author":"II Wistuba","year":"1999","journal-title":"Clin Cancer Res"},{"issue":"1","key":"ref96","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.lungcan.2011.05.020","article-title":"Establishment and comparative characterization of novel squamous cell non-small cell lung cancer cell lines and their corresponding tumor tissue","volume":"75","author":"S Gottschling","year":"2012","journal-title":"Lung Cancer"},{"issue":"19","key":"ref97","doi-asserted-by":"crossref","first-page":"12357","DOI":"10.1073\/pnas.192240599","article-title":"Integrated classification of lung tumors and cell lines by expression profiling","volume":"99","author":"C Virtanen","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"ref98","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1042\/BJ20080309","article-title":"The selectivity of inhibitors of protein kinase CK2: an update","volume":"415","author":"MA Pagano","year":"2008","journal-title":"Biochem J"},{"key":"ref99","doi-asserted-by":"crossref","first-page":"e271","DOI":"10.1038\/cddis.2012.10","article-title":"Inhibition of Casein kinase-2 induces p53-dependent cell cycle arrest and sensitizes glioblastoma cells to tumor necrosis factor (TNFalpha)-induced apoptosis through SIRT1 inhibition","volume":"3","author":"D Dixit","year":"2012","journal-title":"Cell Death Dis"},{"issue":"10","key":"ref100","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1517\/13543784.2012.707192","article-title":"MLN4924: a novel first-in-class inhibitor of NEDD8-activating enzyme for cancer therapy","volume":"21","author":"ST Nawrocki","year":"2012","journal-title":"Expert Opin Investig Drugs"},{"issue":"3","key":"ref101","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.molonc.2012.01.003","article-title":"Inhibition of NEDD8-conjugation pathway by novel molecules: potential approaches to anticancer therapy","volume":"6","author":"T Tanaka","year":"2012","journal-title":"Mol Oncol"},{"issue":"13","key":"ref102","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1158\/0008-5472.CAN-12-0388","article-title":"The Nedd8-activating enzyme inhibitor MLN4924 induces autophagy and apoptosis to suppress liver cancer cell growth","volume":"72","author":"Z Luo","year":"2012","journal-title":"Cancer Res"},{"issue":"6","key":"ref103","doi-asserted-by":"crossref","first-page":"dju083","DOI":"10.1093\/jnci\/dju083","article-title":"Overactivated neddylation pathway as a therapeutic target in lung cancer","volume":"106","author":"L Li","year":"2014","journal-title":"J Natl Cancer Inst"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0165973","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T19:24:22Z","timestamp":1692559462000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0165973"}},"subtitle":[],"editor":[{"given":"Aamir","family":"Ahmad","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2016,11,4]]},"references-count":103,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2016,11,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0165973","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,4]]}}}